Immunization withLeishmaniaVaccine-Alum-BCG and Montanide ISA 720 Adjuvants Induces Low-Grade Type 2 Cytokines and High Levels of IgG2 Subclass Antibodies in the Vervet Monkey (Chlorocebus aethiops) Model-Reference-Cited by-同舟云学术

Immunization withLeishmaniaVaccine-Alum-BCG and Montanide ISA 720 Adjuvants Induces Low-Grade Type 2 Cytokines and High Levels of IgG2 Subclass Antibodies in the Vervet Monkey (Chlorocebus aethiops) Model

Published:2012-10-10 Issue:5 Volume:76 Page:471-477
ISSN:0300-9475
Container-title:Scandinavian Journal of Immunology
language:en
Short-container-title:Scand J Immunol

Author:

Mutiso J. M.,Macharia J. C.,Gicheru M. M.

Publisher

Wiley

Subject

Immunology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-3083.2012.02764.x/fullpdf

Reference26 articles.

1. Immunosuppression in Kenyan visceral leishmaniasis;Ho;Clin Exp Immunol,1983

2. Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis;Carvalho;J Clin Invest,1985

3. Suppression of IL-2 production by cryopreserved peripheral blood mononuclear cells from patients with active visceral leishmaniasis in Sicily;Cillari;J Immunol,1988

4. Interleukin 10 production correlates with pathology in human Leishmania donovani infections;Ghalib;J Clin Invest,1993

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Central and Effector Memory Human CD4+ and CD8+ T Cells during Cutaneous Leishmaniasis and after In Vitro Stimulation with Leishmania (Viannia) braziliensis Epitopes;Vaccines;2023-01-11

2. Development of anti-thrombotic vaccine against human S100A9 in rhesus monkey;Scientific Reports;2021-06-01

3. Review on the Role of Host Immune Response in Protection and Immunopathogenesis during Cutaneous Leishmaniasis Infection;Journal of Immunology Research;2020-06-18

4. Assessment of the immunogenicity of the leptospiral LipL32, LigAni, and LigBrep recombinant proteins in the sheep model;Comparative Immunology, Microbiology and Infectious Diseases;2019-08

5. Visceral leishmaniasis: An overview of vaccine adjuvants and their applications;Vaccine;2019-06